NELSON v. SPARK THERAPEUTICS, INC.

CourtDistrict Court, E.D. Pennsylvania
DecidedJanuary 10, 2024
Docket2:23-cv-00843
StatusUnknown

This text of NELSON v. SPARK THERAPEUTICS, INC. (NELSON v. SPARK THERAPEUTICS, INC.) is published on Counsel Stack Legal Research, covering District Court, E.D. Pennsylvania primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
NELSON v. SPARK THERAPEUTICS, INC., (E.D. Pa. 2024).

Opinion

IN THE UNITED STATES DISTRICT COURT FOR THE EASTERN DISTRICT OF PENNSYLVANIA

GARY NELSON : CIVIL ACTION : v. : : SPARK THERAPEUTICS, INC. and : ROCHE DIAGNOSTICS CORPORATION : NO. 23-843

MEMORANDUM Savage, J. January 10, 2024

Following his termination, plaintiff Gary Nelson initiated this disability discrimination action under the Americans with Disabilities Act (ADA), 42 U.S.C. §§ 12101 et. seq, against his former employer, defendant Spark Therapeutics, Inc. (“Spark”).1 Spark moves for summary judgment, arguing that Nelson cannot prove that his termination was based on discrimination. It contends that Nelson’s supervisor, Luann Sievern, eliminated his position for nondiscriminatory budgetary reasons. Nelson counters that Sievern harbored animus towards him following her learning of his medical conditions and that her reduction-in-force rationale is pretext for disability discrimination. Summary Judgment Standard Summary judgment is appropriate “if the movant shows that there is no genuine dispute as to any material fact and [that] the movant is entitled to judgment as a matter of law.” Fed. R. Civ. P. 56(a). Judgment will be entered against a party who fails to

1 Nelson filed an employment discrimination complaint against Spark and Roche Diagnostics Corporation under the ADA, the Age Discrimination in Employment Act (ADEA), and the Pennsylvania Human Relations Act (PHRA). Compl., ECF No. 1. Pursuant to the parties’ stipulation, we dismissed all claims against Roche Diagnostics Corporation and Nelson’s ADEA count. Order, ECF No. 25. On December 27, 2023, the parties stipulated that Nelson may file an Amended Complaint naming only Spark Therapeutics as a defendant and explicitly requesting relief under the PHRA. Stip. to Amend, ECF No. 40. They agreed that Spark’s Motion for Summary Judgment filed on October 13, 2023, is intended to address all state claims under the PHRA. Id. sufficiently establish any element essential to that party’s case and who bears the ultimate burden of proof at trial. See Celotex Corp. v. Catrett, 477 U.S. 317, 322 (1986). In examining a motion for summary judgment, we must view the facts in the light most favorable to the nonmovant and draw all reasonable inferences in his favor. Young

v. Martin, 801 F.3d 172, 177 (3d Cir. 2015) (citation omitted). Disagreements over what inferences may be drawn from the facts, even undisputed ones, preclude summary judgment. Revock v. Cowpet Bay W. Condo. Ass'n, 853 F.3d 96, 112 (3d Cir. 2017) (citing Windsor Sec., Inc. v. Hartford Life Ins. Co., 986 F.2d 655, 659 (3d Cir. 1993)). Credibility determinations, the drawing of legitimate inferences from facts, and the weighing of evidence are matters left to the jury. In re Asbestos Prod. Liab. Litig. (No. VI), 822 F.3d 125, 135 (3d Cir. 2016) (citing Anderson v. Liberty Lobby, 477 U.S. 242, 255 (1986)). Analysis Nelson had a multitude of health conditions.2 He had seven vertebrae replaced in his back, a rod inserted in his right leg, and a left knee replacement, for which he uses a

cane on an “as-needed basis.”3 He has hearing loss and uses hearing aids.4 He was diagnosed with Bradycardia and diverticulitis.5 He takes Relpax and receives injections for migraines, takes Topomax for seizures, and receives blood transfusions for abnormal

2 Spark admits only that Nelson testified in his deposition about his medical conditions. It concedes that he is disabled only for the purposes of summary judgment. Pl.’s Counter Stmt. of Material and Disputed Facts ¶¶ 41-47, ECF No. 33-1 [“PSF”] (attached to Pl.’s Mem. of L. in Opp’n to Def.’s Mot. for Summ. J., ECF No. 33 [“Pl.’s Resp.”]); Def. Spark Therapeutics, Inc.’s Resp. to Pl.’s Counterstatement of “Material and Disputed Facts” ¶¶ 41-47, ECF No. 37-1 [“DRPSF”] (attached as Ex. A to Def. Spark Therapeutics, Inc.’s Reply Br. in Supp. of Its Mot. for Summ. J., ECF No. 37 [“Def.’s Reply”]). 3 Nelson Dep. 15:14-15; 17:2-21; 21:8-24; 26:2-12; 45:2-5, ECF No. 33-2 (attached as Ex. 3 to Pl.’s Resp.). 4 Id. 53:19; 57:16-18. 5 Id. 38:22-39:1; 54:6-15. 2 red blood cell counts.6 He has been treated by a neurologist for hand tremors, short-term memory loss, and seizures. He has had tumors from his nose, head, and back removed.7 Spark does not dispute that Nelson emailed Sievern about his medical issues and healthcare appointments.8 Nelson agrees that her responses were cordial and repeatedly

reflected wishes that he get well.9 But, Nelson testified that although their working relationship “started off well, … it quickly started degrading.”10 He described the decline as “linear … between the breakdown of our relationship with the breakdown of my health.”11 Nelson claims that Sievern ultimately terminated him because he was or was perceived as disabled. Because Nelson is proceeding under a pretext theory and does not present any “direct evidence” of discrimination, his claims are governed by the burden-shifting McDonnell Douglas analysis. Williams v. Phila. Hous. Auth. Police Dep't., 380 F.3d 751, 759 n.3 (3d Cir. 2004) (citing Shaner v. Synthes, 204 F.3d 494, 500 (3d Cir.2000)); McDonnell Douglas Corp. v. Green, 411 U.S. 792, 802 (1973). Under the burden-shifting

McDonnell Douglas analysis, Nelson must first establish a prima facie case of discrimination. Id. Establishing a prima facie case of discrimination “‘is not onerous’ and poses ‘a burden easily met.’” Doe v. C.A.R.S. Prot. Plus, Inc., 527 F.3d 358, 365 (3d Cir. 2008) (quoting Tex. Dep’t of Corr. Affs. v. Burdine, 450 U.S. 248, 253 (1981)). The

6 Id. 52:4-7; 54: 13-15; 68:15-69:4; 80:15-19. 7 Id. 55:21-56:6; 78:4-80:24. 8 Def. Spark Therapeutics, Inc.’s Stmt. of Undisputed Material Facts ¶¶ 87, 89, 91, 93, 95, 98, 100, 102, 104, ECF No. 27-3 [“DSF”]; Pl.’s Resps. To Def.’s Purported Material and Non-Disputed Facts ¶¶ 87, 89, 91, 93, 95, 98, 100, 102, 104, ECF No. 33-3 [“PRDSF”]. 9 DSF ¶¶ 87-105; PRDSF ¶¶ 87-105. 10 Nelson Dep. 204:2-7. 11 Id. 209:12-16. 3 determination of whether a prima facie case has been established is, under most circumstances, a question of law for the court. Wishkin v. Potter, 476 F.3d 180, 185 (3d Cir. 2007) (citing Sarullo v. United States Postal Serv., 352 F.3d 789, 797-98 (3d Cir.2003) (per curiam)).

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Sulima v. Tobyhanna Army Depot
602 F.3d 177 (Third Circuit, 2010)
McDonnell Douglas Corp. v. Green
411 U.S. 792 (Supreme Court, 1973)
Texas Department of Community Affairs v. Burdine
450 U.S. 248 (Supreme Court, 1981)
Anderson v. Liberty Lobby, Inc.
477 U.S. 242 (Supreme Court, 1986)
Robert D. Shaner, Jr. v. Synthes (Usa)
204 F.3d 494 (Third Circuit, 2000)
Sally J. Shellenberger v. Summit Bancorp, Inc
318 F.3d 183 (Third Circuit, 2003)
Doe v. C.A.R.S Protection Plus, Inc.
527 F.3d 358 (Third Circuit, 2008)
Catherine Willis v. Childrens Hospital of Pittsbur
808 F.3d 638 (Third Circuit, 2015)
Liana Revock v. Cowpet Bay West Condominium As
853 F.3d 96 (Third Circuit, 2017)
Christopher Gibbs v. City of Pittsburgh
989 F.3d 226 (Third Circuit, 2021)
Kathleen Fowler v. AT&T Inc
19 F.4th 292 (Third Circuit, 2021)

Cite This Page — Counsel Stack

Bluebook (online)
NELSON v. SPARK THERAPEUTICS, INC., Counsel Stack Legal Research, https://law.counselstack.com/opinion/nelson-v-spark-therapeutics-inc-paed-2024.